JULIE RUBIN: Open Payments
NPI 1093054959 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $77 |
| PFIZER INC. | 2 | $42 |
| Amgen Inc. | 2 | $37 |
| Radius Health, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Globus Medical, Inc. | 1 | $19 |
Products named: JARDIANCE, PREVNAR 20, KISUNLA, Tymlos, FARXIGA, GVOKE HYPOPEN, Cologuard Collection Kit, REPATHA.
Industry payments across MO — which companies pay providers there.
